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SOMATIC CELL CLONING by nuclear transfer hasbeen performed on a number of species, in-
cluding sheep, mice, pigs, cow, cats, goat, rab-
bit, dogs, and horses (Xuemei et al., 2003). Yet,
cloning efficiency, as determined by the number
of offspring produced over the total number of
oocytes injected, is fairly low (Hill et al., 2000;
Wakayama, 2003). For example, Wakayama
(2003) observed that cloning efficiency ranged
from 1% to 2% in mice, and Wells et al. (1999)
cloned calves from granulosa cells with a
cloning efficiency of about 1.8%. In addition to
cloning efficiency, the health and viability of
clones is low as compared to those produced by
normal reproduction (Cibelli et al., 2002), with
clones often showing a high incidence of devel-
opmental abnormalities (Garry et al., 1996). For
example, Hill et al. (1999) did a thorough anal-
ysis of cloned calves and fetuses, and observed
cardiopulmonary and placental abnormalities,
including neonatal respiratory distress and pla-
cental edema in almost all the clones. In addi-
tion, mouse clones have a shorter life span than
uncloned mice, and Dolly, the famous cloned
sheep, showed symptoms of arthritis often ob-
served with aging (Ogonuki et al., 2002; Dyer,
2002).
A number of reasons have been suggested for
the low cloning efficiencies and survival rates,
and for the reduced viabilities of clones, includ-
ing incomplete epigenetic reprogramming of the
donor cell nuclei, histone acetylation and DNA
methylation, cell-cycle status of donor cell, telo-
mere length of cloned oocytes, and X-chromo-
some inactivation (Wilmut et al., 2002; Lanza et
al., 2000). We would like to emphasize that an-
other factor may also reduce cloning efficiency:
the accumulation of new deleterious mutations
over time in the somatic cells that are used for
cloning.
HIGH RATE OF GENETIC DAMAGE IN
SOMATIC CELLS
Recent studies show that rates of spontaneous
deleterious gene mutations, trinucleotide repeats,
chromosomal rearrangements, and aneuploidy in
germ and somatic cells are higher than was
thought in the past (Crow, 2000; Roland, 1999). For
example, it has been estimated that there are at
least three to six new recessive deleterious muta-
tions in each human (Eyre-Walker and Keightley,
1999), and about one gamete in a thousand con-
tains DNA transposition events that are often the
cause of chromosomal rearrangements (Muotri et
al., 2005). The in vitro and in vivo somatic cell rates
of mutation are about three to 10 times higher than
germinal rates (Neel, 1983; Drake et al., 1998).
Thus, somatic cells may carry even more new dele-
terious mutations than germinal cells. The accu-
mulation of deleterious mutations and the occur-
rence of aneuploidy in somatic cells during
development not only cause cancer (Simpson,
1997; Hanks et al., 2004) but also reduce the fitness
and lifespan of the hosts (Odagiri et al., 1999;
Woodruff and Nikitin, 1995). Deleterious genetic
damage may also reduce the health, fitness, and
lifespan of clones that are formed from somatic
cells.
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ROLE OF NEW GENETIC DAMAGE 
IN CLONING
The possible effect of new deleterious muta-
tions in somatic cells on cloning efficiency and vi-
ability of clones has indirectly been tested by
cloning from various somatic cell types from
adults, newborns, and fetuses (Kato et al., 2000;
Hill et al., 2000). In these studies, the cells from
newborns showed higher cloning efficiency, a re-
sult that was also observed in the early cloning
experiments with frogs where blastula cells of
various stages were used for cloning (Briggs and
King, 1952). Fetal loss and low viability were of-
ten observed in clones derived from adult cells.
Bernstein et al. (1996) have also proposed that
cells from ear and skin tissue are less suitable for
cloning due to genetic damage by ultraviolet
light, and Kato et al. (2000) have suggested that
somatic mutations could lower cloning efficiency
and be responsible for developmental abnormal-
ities. Serial cloning experiments by somatic nu-
clear transfer show decreased efficiency and in-
creased embryonic and fetal mortality with each
generation (Kubota et al., 2004). This is expected,
since clones made from clones would have more
cell divisions and, hence, more new deleterious
mutations.
One possible reason for the short life span of
Dolly was aging effect (Roland, 1999; Shiels et al.,
1999). She developed symptoms of arthritis and
joint disease common in middle-aged sheep. The
role of somatic mutations on aging has been dis-
cussed by many authors (Woodruff and Thomp-
son, 2003). Thus, the accumulation of deleterious
mutations in the udder cells from which Dolly
was cloned could have been one of the reasons
for her poor health. A low rate of homologous re-
combination in somatic cells is considered to be
another obstacle to successful cloning (Cibelli et
al., 2002). This could be indirectly related to the
fact that deleterious mutations cannot be re-
moved in bunches by recombination in somatic
cells. Hence, clones from older cells would be less
fit due to additional genetic damage from the ac-
cumulation of new deleterious mutations.
In support of the role of mutations in cloning,
it has been observed that the survival rate of em-
bryos is higher when embryonic stem (ES) cells
are used for cloning (Rideout et al., 2000). This is
due to reduced reprogramming requirement and
low mutation rates of the ES cells. Stem cells may
be less prone to the accumulation of mutations,
since DNA strands with higher amounts of ge-
netic damage are eliminated as proposed by the
immortal strand hypothesis (Cairns, 1975). Use of
ES cells may overcome some of the mutation
problems, but it has been observed that ES cell
lines also accumulate mutations over time, and
should be used with caution and be monitored
regularly for DNA and chromosomal changes
(Anirban et al., 2005). Some organisms have
evolved strategies to eliminate cells with dam-
aged DNA before they enter mitosis, thereby re-
ducing the accumulation of mutations (Raff et al.,
2003).
CONCLUSION
Cloning has promising applications, but the
major problems of low cloning efficiency, and
poor fitness and viability of clones must be
solved. We propose that the accumulation of new
deleterious gene and chromosomal mutations in
somatic cells could be one of the causes of re-
duced cloning efficiency and compromised
health of cloned animals. The tactic of using
younger donor cells could reduce some of these
cloning problems. In some cases, this would re-
quire the cryopreservation of younger cells for
use in future cloning experiments.
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